Molecular genetic testing does not improve the detection of fluoroquinolone resistance before transrectal prostate biopsy

BACKGROUND: Fluoroquinolone-resistant (FQR) Escherichia coli (E. coli) causes transrectal prostate biopsy infections. We seek to further identify fluoroquinolones resistance by the incorporation of genetic profiling to influence antibiotic selection for transrectal prostate biopsy and whether the ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Liss, Michael A., Garg, Harshit, Sokurenko, Evgeni V., Patterson, Jan E., Wickes, Brian L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747570/
https://www.ncbi.nlm.nih.gov/pubmed/36570643
http://dx.doi.org/10.1016/j.prnil.2022.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747570/
https://www.ncbi.nlm.nih.gov/pubmed/36570643
http://dx.doi.org/10.1016/j.prnil.2022.06.005

Ejemplares similares